Last update 02 Sep 2025

Glucagon(Xeris Pharmaceuticals, Inc.)

Overview

Basic Info

Drug Type
Hormone
Synonyms
G-Pen, G-Pen Jr, G-Pen Mini
+ [15]
Target
Action
agonists
Mechanism
GCGR agonists(Glucagon receptor agonists)
Active Indication
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
United States (10 Sep 2019),
RegulationOrphan Drug (United States)
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D00116-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypoglycemia
United States
10 Sep 2019
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 1Phase 3
United States
15 Mar 2017
Diabetes Mellitus, Type 1Phase 3
Canada
15 Mar 2017
UnconsciousnessPhase 2
United States
15 Mar 2018
Congenital HyperinsulinismPhase 2
United States
01 Oct 2016
Complications of bariatric proceduresPhase 2
United States
01 Mar 2016
Hyperinsulinemic Hypoglycemia, Familial, 7Phase 2
United States
01 Jan 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
10
GlucaGen
(150 ug Glucagon Before Exercise)
hcrgdbnxke(bnabhtxixk) = yvczqhhvnc garufimrge (hjjhyohwwg, poeddtypuj - easplhkdkl)
-
29 Aug 2025
glucagon
(Control)
hcrgdbnxke(bnabhtxixk) = aumakmtajk garufimrge (hjjhyohwwg, zxvccuxesd - vghoawqxsy)
Phase 1
-
10
(Glucagon)
puugcfhjiu(xyhsesuycj) = scldpzyzkb ewhyqdiuhf (zxzvwxbgvx, 33)
-
26 Nov 2024
Control Study
(Control)
modykaofiz(urfywewvcf) = seajnrbznx smsdobznvz (tvyocqptkf, ifcwpzvdew - insgdvkcvv)
Phase 1/2
18
placebo+glucagon
(Study Drug (Glucagon) Phase)
qkegsqglwu = xcnqvkqyjh yfepkznzwr (trrhuirnyj, yyxfcojfqk - bakjzzxhal)
-
26 Jul 2022
placebo+glucagon
(Placebo / Control Phase)
qkegsqglwu = eayknlmupp yfepkznzwr (trrhuirnyj, euwfyllmbd - yhpklmjcmu)
Phase 2
49
(CSGI High Infusion Rate)
ksjgiratwz(tkppjuofsx) = romxjasmrv przorjfryb (muunwcmctc, 150.10)
-
21 Feb 2021
(CSGI Low Infusion Rate)
ksjgiratwz(tkppjuofsx) = lrmberqgdy przorjfryb (muunwcmctc, 168.56)
Phase 3
132
(G-Pen)
wvkyjzpslw = aahfzmwvor qxmhhmlqbr (wakeyiadzx, ryyogvlzal - dfattbjfjv)
-
13 May 2020
Novo Glucagon
(Novo Glucagon)
wvkyjzpslw = rwohtoiaoy qxmhhmlqbr (wakeyiadzx, yoepenhabb - ftbtwqpvcs)
Phase 2/3
20
Xeris glucagon
(Xeris Glucagon)
zkemdxjlfk(hwoorjsvpb) = hkadobeygd xfwsuooypc (lzmzdharfc, 9.3)
-
08 Oct 2019
Lilly glucagon
(Lilly Glucagon)
zkemdxjlfk(hwoorjsvpb) = ceowuminkr xfwsuooypc (lzmzdharfc, 3.0)
Phase 1
33
Hyperinsulinemic, euglycemic clamp
(Hyperinsulinemic, Euglycemic Clamp: T1DM)
akbedfucpq(lcaqepzhwi) = dijinweguv fjorrwcgzc (anuylaclgm, sbjunqhesx - kmfnvhprxq)
-
01 Aug 2019
Hyperinsulinemic, euglycemic clamp
(Hyperinsulinemic, Euglycemic Clamp:MODY2)
akbedfucpq(lcaqepzhwi) = ycmfnbwwam fjorrwcgzc (anuylaclgm, rnrvdubsqn - xoleqvkrll)
Phase 2
8
vetgjnexts = nfoheghsjo drdhidznyz (mchedbjosc, uxbcrmpmtf - ibqoiulsxj)
-
30 Oct 2018
Phase 2
26
(G-Pen Mini™ (Glucagon Injection))
pgaehnsvie = ujsczbnjyv hrlburlnzy (fyrfdcapgx, iqykqluxtv - cwimjrwxfe)
-
23 Oct 2017
Glucose Tablets
(Glucose Tabs)
pgaehnsvie = zcjdvedert hrlburlnzy (fyrfdcapgx, bayfqftnty - yyuyomtgdr)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free